Concepedia

Author

Kathryn Winter

The University of Texas MD Anderson Cancer Center

Also Known As

K A WINTER, K A Winter, K. A. Winter, K.A. Winter, K.A.H. Winter, Kathryn Winter

27

Publications

1.9K

Citations

14

H-Index

51

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterRTOG FoundationMayo Clinic in ArizonaDuke Medical CenterFox Chase Cancer Center
KW

About

Kathryn Winter is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

772

2

Health Sciences

7

7

550

3

Engineering

1

1

25

4

Biomedical Engineering

1

1

25

5

Cell Biology

1

1

25

Kathryn Winter

×

17

Publications

1.9K

Citations

14

H-Index

YearCitations

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

William U. Shipley, Kathryn Winter, Donald S. Kaufman,

Journal of Clinical Oncology

1998

484

Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response

Jaffer A. Ajani, Kathryn Winter, Gordon Okawara,

Journal of Clinical Oncology

2006

382

Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial

Jeff M. Michalski, Yan Yan, Deborah Watkins Bruner,

International Journal of Radiation Oncology*Biology*Physics

2013

304

Randomized Phase II Study of Neoadjuvant Combined-Modality Chemoradiation for Distal Rectal Cancer: Radiation Therapy Oncology Group Trial 0012

Mohammed Mohiuddin, Kathryn Winter, Edith P. Mitchell,

Journal of Clinical Oncology

2006

252

A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0418

Anuja Jhingran, Kathryn Winter, Lorraine Portelance,

International Journal of Radiation Oncology*Biology*Physics

2012

96

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

Stuart J. Wong, Kathryn Winter, Neal J. Meropol,

International Journal of Radiation Oncology*Biology*Physics

2011

85

Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05

Steven J. Feigenberg, W. Robert Lee, Michelle DeSilvio,

International Journal of Radiation Oncology*Biology*Physics

2005

61

Intergroup RTOG 98–11: A phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal

Jaffer A. Ajani, Kathryn Winter, Leonard L. Gunderson,

Journal of Clinical Oncology

2006

53

Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.

Lisa A. Kachnic, Kathryn Winter, Robert J. Myerson,

Journal of Clinical Oncology

2011

36

Do Intermediate Radiation Doses Contribute to Late Rectal Toxicity? An Analysis of Data From Radiation Therapy Oncology Group Protocol 94-06

Susan L. Tucker, Lei Dong, Jeff M. Michalski,

International Journal of Radiation Oncology*Biology*Physics

2012

30

Page 1